Compare SRFM & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRFM | RPID |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.5M | 102.6M |
| IPO Year | 2023 | 2021 |
| Metric | SRFM | RPID |
|---|---|---|
| Price | $0.73 | $2.11 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $3.25 | ★ $8.00 |
| AVG Volume (30 Days) | ★ 3.8M | 216.9K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.69 | 2.78 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $106,557,000.00 | $33,587,000.00 |
| Revenue This Year | $25.90 | $19.12 |
| Revenue Next Year | $20.72 | $18.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.74 |
| 52 Week Low | $0.67 | $1.66 |
| 52 Week High | $6.17 | $4.94 |
| Indicator | SRFM | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 34.04 | 56.29 |
| Support Level | $0.67 | $1.98 |
| Resistance Level | $1.33 | $2.17 |
| Average True Range (ATR) | 0.07 | 0.16 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 12.53 | 61.11 |
Surf Air Mobility Inc is a regional air mobility platform operating commuter airlines in the United States and expanding an on-demand charter marketplace for passengers in the U.S. and globally. It is also focused on developing a proprietary aviation software, aircraft electrification powertrain technology and services to enable electrification across the regional air mobility sector. The company operates in a single reportable segment, Air Mobility. The Air Mobility segment derives revenue from operating scheduled commercial air service flights, which are sold to the public mainly on a per-seat basis; through subsidized EAS revenue awards from the Department of Transportation; and by operating on-demand flights for customers on an ad-hoc, by request basis.
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.